PubRank

Clinical positron imaging : official journal of the Institute for Clinical P.E.T (Clin Positron Imaging)

Journal PubWeight™ 0.00‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. 1999 2.43
2 Combined PET/CT Imaging in Oncology. Impact on Patient Management. 2000 1.38
3 Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner. 1998 1.31
4 Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease. 1999 1.26
5 Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. 1998 1.11
6 Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. 1999 1.06
7 22. FDG Uptake in Infectious Mononucleosis. 2000 1.01
8 Superphysiologic FDG Uptake in the Non-Paralyzed Vocal Cord. Resolution of a False-Positive PET Result with Combined PET-CT Imaging. 2000 1.00
9 FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CT. 1998 0.99
10 Quantitative Imaging of Yttrium-86 with PET. The Occurrence and Correction of Anomalous Apparent Activity in High Density Regions. 2000 0.98
11 Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. 2000 0.97
12 Diabetes Decreases FDG Accumulation in Primary Lung Cancer. 1999 0.96
13 Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them? 1999 0.95
14 Radiation Dose Assessment for I-131 Therapy of Thyroid Cancer Using I-124 PET Imaging. 1999 0.92
15 9:30-9:45. First Pass FDG Measured Blood Flow in Tumors: A Comparison with O-15 Labeled Water Measured Blood Flow. 2000 0.92
16 Image Fusion System Using PACS for MRI, CT, and PET Images. 1999 0.89
17 FDG-PET Evaluation of Carcinoma of the Cervix. 1999 0.87
18 Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer. 1999 0.87
19 31. Clinical Application of 2000 0.86
20 16. FDG-PET in the Detection of Recurrence in Colorectal Cancer Based on Rising CEA Level. Experience in 72 Patients. 2000 0.85
21 Clinical PET in Oncology. 1998 0.85
22 Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft. 1999 0.84
23 Response of Osteosarcoma to Chemotherapy. Evaluation with F-18 FDG-PET Scans. 2000 0.84
24 Tumor Burden Assessment with Positron Emission Tomography with 2000 0.84
25 Possibility of Differential Diagnosis of Small Polypoid Lesions in the Gallbladder Using FDG-PET. 2000 0.84
26 PET Scanning with (18)F 2-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Melanoma. Benefits and Limitations. 1999 0.83
27 Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. 1999 0.83
28 Positron Emission Tomography (PET) with 1-Aminocyclobutane-1-[(11)C]carboxylic Acid (1-[(11)C]-ACBC) for Detecting Recurrent Brain Tumors. 1998 0.82
29 5. Utility of F-18 FDG Imaging for Diagnosing the Infected Joint Replacement. 2000 0.82
30 Staging Hodgkin's Disease with 18-FDG PET. Comparison with CT and Surgery. 1998 0.82
31 A Coordinate System for Tumor Identification in Positron Emission Tomography (PET) Imaging. 2000 0.82
32 Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels. 2000 0.82
33 24. The Fusion of Anatomic and Physiologic Tomographic Images to Enhance Accurate Interpretation. 2000 0.81
34 Attenuation-Correction Induced Artifact in F-18 FDG PET Imaging Following Total Knee Replacement. 2000 0.81
35 18F-FDG Uptake in the Anterior Mediastinum. Physiologic Thymic Uptake or Disease? 2000 0.81
36 Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission Tomography. 1999 0.80
37 Evaluation of the Effect of Radiation Therapy to Nasopharyngeal Carcinoma by Positron Emission Tomography with 2- 2000 0.80
38 1. Positron Emission Tomography of Thoracic Malignancies. Reduction of Myocardial Fluorodeoxyglucose Uptake Artifacts With a Carbohydrate Restricted Diet. 2000 0.80
39 The Changing Design of Positron Imaging Systems. 1998 0.80
40 28. Accuracy of Qualitative and Semiquantitative Analysis of 18FDG Positron Emission Tomography Scans in the Evaluation of Primary and Metastatic Lesions. 2000 0.79
41 Development and Reliability of a Method for Using Magnetic Resonance Imaging for the Definition of Regions of Interest for Positron Emission Tomography. 1998 0.79
42 Cost Analysis of FDG PET for Managing Patients with Ovarian Cancer. 1999 0.78
43 Intraindividual Comparison of F-18-Fluorodeoxyglucose and Tc-99m-Tetrofosmin in Planar Scintimammography and SPECT. 2000 0.78
44 Clinical Applications of [(15)O] H(2)O PET Activation Studies. 1999 0.78
45 FDG PET for Evaluation of Bronchioloalveolar Cell Carcinoma (BAC) of the Lung. 1998 0.78
46 8:45-9:00. Using PET 18F-FDG, 11CO, and 15O-water for Monitoring Prostate Cancer During a Phase II Anti-angiogenic Drug Trial with Thalidomide. 2000 0.78
47 F-18 Fluorodeoxyglucose (FDG) and C-Reactive Protein (CRP). 1999 0.78
48 Detection of Intramural Choriocarcinoma of the Uterus with 18F-FDG-PET. A Case Report. 2000 0.78
49 8:45-90:00. The Influence of a High Fat Meal Compared to an Olestra Meal on Coronary Artery Endothelial Dysfunction by Rubidium (Rb)-82 Positron Emission Tomography (PET) and on Post Prandial Serum Triglycerides. 2000 0.78
50 Utility of PET in Breast Cancer. 1999 0.78
Next 50